This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Njoku, C. J. Articles by Stich, R. W. Search for Related Content PubMed PubMed Citation Articles by Njoku, C. J. Articles by Stich, R. W.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, May 2002, p. 605-610, Vol. 9, No. 3
1071-412X/02/$04.00+0     DOI: 10.1128/CDLI.9.3.605-610.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Reduced Levels of Nitric Oxide Metabolites in Cerebrospinal Fluid Are Associated with Equine Protozoal Myeloencephalitis

Chinedu J. Njoku,¹ William J. A. Saville,¹ Stephen M. Reed,² Michael J. Oglesbee,³ Päivi J. Rajala-Schultz,¹ and Roger W. Stich^1*

Department of Veterinary Preventive Medicine,¹ Department of Veterinary Clinical Sciences,² Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio 43210³

Received 23 July 2001/ Returned for modification 3 October 2001/ Accepted 7 January 2002

Equine protozoal myeloencephalitis (EPM) is a disease of horses that is primarily associated with infection with the apicomplexan Sarcocystis neurona. Infection with this parasite alone is not sufficient to induce the disease, and the mechanism of neuropathogenesis associated with EPM has not been reported. Nitric oxide (NO) functions as a neurotransmitter, a vasodilator, and an immune effector and is produced in response to several parasitic protozoa. The purpose of this work was to determine if the concentration of NO metabolites (NO_x^-) in the cerebrospinal fluid (CSF) is correlated with the development of EPM. CSF NO_x^- levels were measured before and after transport-stressed, acclimated, or dexamethasone-treated horses (n = 3 per group) were experimentally infected with S. neurona sporocysts. CSF NO_x^- levels were also compared between horses that were diagnosed with EPM after natural infection with S. neurona and horses that did not have clinical signs of disease or that showed no evidence of infection with the parasite (n = 105). Among the experimentally infected animals, the mean CSF NO_x^- levels of the transport-stressed group, which had the most severe clinical signs, was reduced after infection, while these values were found to increase after infection in the remaining groups that had less severe signs of EPM. Under natural conditions, horses with EPM (n = 65) had a lower mean CSF NO_x^- concentration than clinically normal horses with antibodies (Abs) against S. neurona (n = 15) in CSF, and horses that developed ataxia (n = 81) had a significantly lower mean CSF NO_x^- concentration than horses that did not have neurologic signs (n = 24). In conclusion, lower CSF NO_x^- levels were associated with clinical EPM, suggesting that measurement of CSF NO_x^- levels could improve the accuracy of diagnostic tests that are based upon detection of S. neurona-specific Abs in CSF alone and that reduced NO levels could be causatively related to the development of EPM.

---

* Corresponding author. Mailing address: Department of Veterinary Preventive Medicine, The Ohio State University, 1900 Coffey Rd., Columbus, OH 43210-1092. Phone: (614) 292-9702. Fax: (614) 292-4142. E-mail: stich.2{at}osu.edu.

---

Clinical and Diagnostic Laboratory Immunology, May 2002, p. 605-610, Vol. 9, No. 3
1071-412X/02/$04.00+0     DOI: 10.1128/CDLI.9.3.605-610.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.